Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: A paired study before and after treatment

被引:159
作者
Misof, BM
Roschger, P
Cosman, F
Kurland, ES
Tesch, W
Messmer, P
Dempster, DW
Nieves, J
Shane, E
Fratzl, P
Klaushofer, K
Bilezikian, J
Lindsay, R
机构
[1] Hanusch Hosp, Ludwig Boltzman Inst Osteol, A-1140 Vienna, Austria
[2] Hanusch Hosp, Dept Med 4, A-1140 Vienna, Austria
[3] UKH Meidling, A-1140 Vienna, Austria
[4] Austrian Acad Sci, Erich Schmid Inst Mat Sci, A-8700 Leoben, Austria
[5] Univ Min & Met Leoben, A-8700 Leoben, Austria
[6] Helen Hayes Hosp, Reg Bone Ctr, W Haverstraw, NY 10993 USA
[7] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA
关键词
D O I
10.1210/jc.2002-021988
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Anabolic effects of PTH have been observed at several skeletal sites in humans by dual x-ray absorptiometry without differentiating between an actual increase in bone volume and an increase in mineral content within already established bone. The present study addressed this issue by evaluating the bone mineralization density distribution of iliac crest bone biopsies before and after PTH treatment for 18-36 months in men and women with osteoporosis using quantitative backscattered electron imaging. In cortical bone, pairwise comparison of the two biopsies before and after treatment revealed a reduction in the typical calcium concentration in men (-3.32%; P = 0.02, by paired t test), but no change in women, and the heterogeneity of mineralization increased in both males and females [+18.80% (P = 0.09) and +18.14% (P = 0.005), respectively]. In cancellous bone, there was no change in the typical calcium concentration, but there was a greater heterogeneity of mineralization in both men and women [+19.65% (P = 0.02) and +21.59% (P = 0.056), respectively] due to newly formed bone matrix. Small angle x-ray scattering performed on a subgroup of subjects revealed normal collagen/mineral structure. The findings confirm the observations that PTH stimulates skeletal remodeling, resulting in an increased percentage of newly formed bone matrix of lower mineral density.
引用
收藏
页码:1150 / 1156
页数:7
相关论文
共 25 条
[1]   Studies of calcium and phosphorus metabolism. V. A study of the bone trabeculae as a readily available reserve supply of calcium. [J].
Bauer, W ;
Aub, JC ;
Albright, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1929, 49 (01) :145-U19
[2]   Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women [J].
Boivin, GY ;
Chavassieux, PM ;
Santora, AC ;
Yates, J ;
Meunier, PJ .
BONE, 2000, 27 (05) :687-694
[3]  
BOYDE A, 1986, Scanning Electron Microscopy, P1537
[4]   Parathyroid hormone added to established hormone therapy: Effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal [J].
Cosman, F ;
Nieves, J ;
Woelfert, L ;
Formica, C ;
Gordon, S ;
Shen, V ;
Lindsay, R .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (05) :925-931
[5]   Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis:: A paired biopsy study [J].
Dempster, DW ;
Cosman, F ;
Kurland, ES ;
Zhou, H ;
Nieves, J ;
Woelfert, L ;
Shane, E ;
Plavetic, K ;
Müller, R ;
Bilezikian, J ;
Lindsay, R .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (10) :1846-1853
[6]  
FRATZL P, 1994, J BONE MINER RES, V9, P1541
[7]  
Fratzl P, 1996, Connect Tissue Res, V34, P247, DOI 10.3109/03008209609005268
[8]  
Fratzl P, 1996, J BONE MINER RES, V11, P248
[9]   A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis [J].
Hodsman, AB ;
Fraher, LJ ;
Watson, PH ;
Ostbye, T ;
Stitt, LW ;
Adachi, JD ;
Taves, DH ;
Drost, D .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (02) :620-628
[10]   Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis [J].
Hodsman, AB ;
Kisiel, M ;
Adachi, JD ;
Fraher, LJ ;
Watson, PH .
BONE, 2000, 27 (02) :311-318